Skip to main content

Drug Interactions between Orthovisc and sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

hyaluronan SARS-CoV-2 mRNA (tozinameran-tris-sucrose) vaccine

Applies to: Orthovisc (hyaluronan) and sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine

The following interaction applies only to products containing hyaluronic acid for use as a dermal filler. It does not apply to products containing hyaluronic acid that are used for other purposes.

If you received a dermal filler with hyaluronan, you may have a low risk of experiencing temporary swelling at or near the site of the filler following a dose of SARS-CoV-2 mRNA (tozinameran-tris-sucrose) vaccine. Contact your doctor or seek immediate medical treatment if you experience any swelling, discoloration, painful areas, or thickening/hardening at or near the site of your dermal filler. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer